You may not be familiar with Wolters Kluwer, but if you’re a pharmacist I’m sure you are familiar with their products: Facts & Comparisons, Medi-Span, Ovid, ProVation Medical, UpToDate. While Facts & Comparisons has become an afterthought in the drug information world, products like UpToDate and ProVation Medical are gaining traction in the healthcare industry. This is especially true as physicians, pharmacists and other healthcare providers look for ways to access information while on the go, i.e. access from mobile devices.
Wolters and Kluwer just bolstered their position and gained significantly more credibility with their purchase of Pharmacy OneSource. Pharmacy OneSource is the maker of several innovative pharmacy products such as Accupedia pediatric dosing software, Sentri 7 clinical surveillance software and Quantifi for pharmacist intervention documentation. Pharmacy OneSource not only provides several interesting and innovative applications, they also offer them by way of the Software-as-a-Service (SaaS) model, which is uncommon in the pharmacy world.
I’ve blogged about Pharmacy OneSource several times as I’m not only a fan of their products, but their distribution model and use of cloud computing as well. It’s no secret that I believe in cloud computing as the future for many applicaitons in pharmacy and feel that Pharmacy OneSource has created a solid foundation on which the rest of the industry can build. My only hope for the Wolters Klumer acquisition of Pharmacy OneSource is that their innovative products and strategy won’t change. Often times the first thing to go when a smaller company is purchased by a larger company is innovation. Here’s hoping that won’t happen.
2 thoughts on “Wolters Kluwer acquires Pharmacy OneSource”
Thanks for posting about our exciting news and for commending us on our history of innovation. We have enjoyed innovating for pharmacy the past ten years and look forward to much more as part of Wolters Kluwer Health.
As two of the co-founders of Pharmacy OneSource, both of us are truly honored to be working with the leading point-of-care solutions provider in the healthcare industry. Over the last few months we have gotten to know the Wolters Kluwer team and culture well. There are many synergies between our companies that we feel will benefit our customers and patients. Innovation and responsiveness to customer needs have been, and will always be important to our mission, and we both feel that combination of our companies will catalyze more innovation as a result.
Thanks again for the post. Let either of us know if you have any further questions.
Charles & Keith
Charles Westergard, BSPharm, MBA, VP Clinical Marketing
Keith Streckenbach, MBA, VP Strategy